These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23701855)

  • 1. Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator: a pilot study.
    Zabarovskaja S; Gadler F; Gabrielsen A; Linde C; Lund LH
    J Heart Lung Transplant; 2013 Jun; 32(6):651-4. PubMed ID: 23701855
    [No Abstract]   [Full Text] [Related]  

  • 2. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cardiac resynchronization therapy and implantable cardioverter defibrillator on quality of life in patients with heart failure: a meta-analysis.
    Chen S; Yin Y; Krucoff MW
    Europace; 2012 Nov; 14(11):1602-7. PubMed ID: 23104857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).
    Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ
    J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation.
    Pedone C; Grigioni F; Boriani G; Lofiego C; Vassallo PL; Potena L; Coccolo F; Magnani G; Biffi M; Martignani C; Frabetti L; Zannoli R; Magelli C; Branzi A
    Am J Cardiol; 2004 Feb; 93(3):371-3. PubMed ID: 14759396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
    Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
    Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy.
    Goda A; Lund LH; Mancini D
    J Heart Lung Transplant; 2011 Mar; 30(3):315-25. PubMed ID: 21093299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of defibrillators and resynchronization therapy at the time of evaluation at a heart failure and cardiac transplantation center.
    Sims DB; Garcia LI; Mignatti A; Colombo PC; Jones M; Uriel N; Mancini DM; Jorde UP
    Pacing Clin Electrophysiol; 2010 Aug; 33(8):988-93. PubMed ID: 20353413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlead difference between T-peak to T-end intervals in resynchronization patients with an implantable cardioverter-defibrillator.
    Suzuki A; Shiga T; Nakai K; Futagawa K; Matsuyama Y; Shoda M; Kasanuki H; Hagiwara N
    J Electrocardiol; 2010; 43(6):706-12. PubMed ID: 20719332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Seattle Heart Failure Model in implantable defibrillator patients treated with cardiac resynchronization therapy.
    Smith T; Levy WC; Schaer BA; Balk AH; Sticherling C; Jordaens L; Theuns DA
    Am J Cardiol; 2012 Aug; 110(3):398-402. PubMed ID: 22516524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All cause mortality of cardiac resynchronization therapy with implantable cardioverter defibrillator: a meta-analysis of randomized controlled trials.
    Huang Y; Wu W; Cao Y; Qu N
    Int J Cardiol; 2010 Dec; 145(3):413-7. PubMed ID: 20541819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
    J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deterioration from improved heart failure status in a recipient of a cardiac resynchronization therapy-defibrillator (CRT-D) following a single inappropriate shock.
    Kantharia BK
    Int J Cardiol; 2012 Nov; 161(3):e55-7. PubMed ID: 22546544
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in intrathoracic impedance measures during acute decompensated heart failure admission: results from the Diagnostic Data for Discharge in Heart Failure Patients (3D-HF) Pilot Study.
    Whellan DJ; Droogan CJ; Fitzpatrick J; Adams S; McCarey MM; Andrel J; Mather P; Rubin S; Bonita R; Keith S
    J Card Fail; 2012 Feb; 18(2):107-12. PubMed ID: 22300777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
    Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
    Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac resynchronization therapy in patients with class I-II heart failure and a wide QRS: a cautionary note.
    Tang WH; Francis GS
    Circulation; 2011 Jan; 123(2):203-8. PubMed ID: 21242506
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial.
    Arshad A; Moss AJ; Foster E; Padeletti L; Barsheshet A; Goldenberg I; Greenberg H; Hall WJ; McNitt S; Zareba W; Solomon S; Steinberg JS;
    J Am Coll Cardiol; 2011 Feb; 57(7):813-20. PubMed ID: 21310317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.